View drug registration information details.
| Items | Registration information |
|---|
| ID | 1588 |
|---|
| No | 1588 |
|---|
| Brand Name | ALICAPASE |
|---|
| Ingredients | CAPIVASERTIB 20 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 64'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | FOR THE TREATMENT OF ADULT PATIENTS WITH HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE, LOCALLY ADVANCED OR METASTATIC BREAST CANCER WITH ONE OR MORE PIK3CA/AKT1/PTEN-ALTERATIONS |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | WHITE TABLETS |
|---|
| Note | |
|---|
| License Owner | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
|---|
| Manufacturer | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 07 L 1133/24 |
|---|
| FDD Registration Date | 12-JUL-2024 |
|---|
| Expiry Date | 11-JUL-2027 |
|---|
Back to drug list
|
